Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Pain Relief & OTC Medication Recalls

Recalls of common over-the-counter and prescription pain relievers.

415 recalls in this category, newest first.

Class II · Moderate risk

Aspirin Chewable tablet 81 mg

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Ongoing Packaging defect Safecor Health, LLC NDC 48433-129-01 D-0058-2025
Class III · Low risk

IBU (ibuprofen)

Failed Tablet/Capsule Specifications

Ongoing Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-683-05 D-0047-2025
Class II · Moderate risk

Ibuprofen 800mg

Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.

Ongoing Impurity / degradation Direct Rx NDC 61919-0621-15 D-0041-2025
Class II · Moderate risk

Ibuprofen Tablets

Failed Impurities/Degradation Specifications - at 18-month Stability testing

Ongoing Impurity / degradation Preferred Pharmaceuticals, Inc. NDC 68788-9110-03 D-0647-2024
Class II · Moderate risk

IBU Ibuprofen Tablets

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Ongoing Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-682-01 D-0646-2024
Class II · Moderate risk

IBU Ibuprofen Tablets

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Ongoing Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-683-01 D-0645-2024
Class II · Moderate risk

IBU Ibuprofen Tablets

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Ongoing Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-684-01 D-0644-2024
Class II · Moderate risk

Gabapentin Tablets

Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets

Terminated Particulate / foreign matter Granules Pharmaceuticals Inc. NDC 70010-227-05 D-0634-2024
Class III · Low risk

Acetaminophen

Label mix-up: Carton incorrectly labeled.

Terminated Labeling / mix-up Granules Consumer Health Inc. D-0627-2024
Class I · High risk

Healthy Living Acetaminophen

Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Ongoing Labeling / mix-up Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class I · High risk

Acetaminophen Injection

Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)

Ongoing Labeling / mix-up Hikma Pharmaceuticals USA Inc. NDC 0143-9386-01 D-0635-2024
Class I · High risk

Acetaminophen Extra Strength Tablets

Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.

Terminated Labeling / mix-up A-S Medication Solutions LLC D-0631-2024
Class II · Moderate risk

TraMADol HCl 50 mg Tablet

Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol

Terminated Particulate / foreign matter RemedyRepack Inc. NDC 70518-3824-00 D-0489-2024
Class II · Moderate risk

Broncochem Cold & Tea

Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.

Ongoing Stability / shelf life Global Corporation NDC 65131-097-12 D-0387-2024
Class II · Moderate risk

Broncochem Cold & Flu Syrup Kids

Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.

Ongoing Stability / shelf life Global Corporation NDC 65131-098-44 D-0386-2024
Class II · Moderate risk

Naproxen Tablets

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Ongoing Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-188-01 D-0124-2024